Literature DB >> 3094210

Immunological characteristics of purified pancreatic islet grafts.

M Gotoh, T Maki, S Satomi, J Porter, A P Monaco.   

Abstract

In a DBA/2 (H-2d) pancreatic islet-to-B6AF1 (H-2b/k.d) recipient combination, the graft survival of hand-picked islets was compared with that of "crude digested" islets that were prepared simply by collagenase digestion and Ficoll gradient separation and were contaminated with lymph nodes and vascular and ductal tissue. Islet allografts were transplanted into the renal subcapsular space of streptozotocin-induced diabetic recipients. No immunosuppression was used. All the crude digested islet allografts were acutely rejected between days 7 and 18 with a median survival time (MST) of 10.2 +/- 2.5 days. In contrast, 33% (3/9) of the purified islet allografts survived more than 100 days. Simultaneous transplantation of purified islets and contaminating tissue resulted in a shorter graft survival (MST of 15.6 +/- 3.7 days). When 5 X 10(7) donor strain spleen cells were injected i.v. at the time of transplantation, all purified islet grafts were acutely rejected within 9 days. In addition, the rejection time of the purified islet allografts was inversely correlated with the number of donor spleen cells injected. These results indicate that contaminating tissues such as lymph nodes, vascular tissue, and ductal fragments present in the crude digested islet allografts are a major stimulus for induction of an immune response resulting in acute rejection of islet allografts.

Entities:  

Mesh:

Year:  1986        PMID: 3094210     DOI: 10.1097/00007890-198610000-00011

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  14 in total

1.  Islet xenografts in fully xenogeneic (rat----mouse) chimeras: evidence for normal regulation of function in a xenogeneic mouse environment.

Authors:  C Ricordi; Y Zeng; P B Carroll; H L Rilo; D R Beretier; T E Starzl; S T Ildstad
Journal:  Surgery       Date:  1992-08       Impact factor: 3.982

2.  Hypothermic Perfusion Preservation of Pancreas for Islet Grafts: Validation Using a Split Lobe Porcine Model.

Authors:  B P Weegman; M J Taylor; S C Baicu; W E Scott; K R Mueller; J D Kitzmann; M D Rizzari; K K Papas
Journal:  Cell Med       Date:  2012-01-01

3.  Demonstration of donor specific unresponsiveness in rat islet allografts: importance of transplant site for induction by cyclosporin A and maintenance.

Authors:  T Kamei; Y Yasunami
Journal:  Diabetologia       Date:  1989-11       Impact factor: 10.122

4.  Stable transplantation results of magnetically retracted islets: a novel method.

Authors:  G G M Pinkse; E Steenvoorde; S Hogendoorn; M Noteborn; O T Terpstra; J A Bruijn; E De Heer
Journal:  Diabetologia       Date:  2003-12-12       Impact factor: 10.122

Review 5.  Clinical islet cell transplantation. Are we there yet?

Authors:  L Rosenberg
Journal:  Int J Pancreatol       Date:  1998-12

6.  Effect of nicotinamide on early graft failure following intraportal islet transplantation.

Authors:  Da-Yeon Jung; Jae Berm Park; Sung-Yeon Joo; Jae-Won Joh; Choon-Hyuck Kwon; Ghee-Young Kwon; Sung-Joo Kim
Journal:  Exp Mol Med       Date:  2009-11-30       Impact factor: 8.718

Review 7.  Current state of hypothermic machine perfusion preservation of organs: The clinical perspective.

Authors:  Michael J Taylor; Simona C Baicu
Journal:  Cryobiology       Date:  2009-10-24       Impact factor: 2.487

8.  Long-term survival of donor-specific pancreatic islet xenografts in fully xenogeneic chimeras (WF rat----B10 mouse).

Authors:  Y J Zeng; C Ricordi; A Tzakis; H L Rilo; P B Carroll; T E Starzl; S T Ildstad
Journal:  Transplantation       Date:  1992-02       Impact factor: 4.939

9.  CD86 has sustained costimulatory effects on CD8 T cells.

Authors:  Ian J Thomas; Liliana G Petrich de Marquesini; Rommel Ravanan; Richard M Smith; Sylvie Guerder; Richard A Flavell; David C Wraith; Li Wen; F Susan Wong
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

10.  Inhalation of glutamic acid decarboxylase 65-derived peptides can protect against recurrent autoimmune but not alloimmune responses in the non-obese diabetic mouse.

Authors:  R Ravanan; S F Wong; N G Morgan; P W Mathieson; R M Smith
Journal:  Clin Exp Immunol       Date:  2007-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.